Table 4.
Adverse effects in the oxybutynin and placebo groups
| Oxybutynin (n = 66) | Placebo (n = 74) | Statistics | |||
|---|---|---|---|---|---|
|
|
|
||||
| Yes | No | Yes | No | ||
| Gastrointestinal complications | 7 (10.6%) | 59 (89.4%) | 6 (8.1%) | 68 (91.9%) | χ2 (df = 1, N = 140) = 0.26, P = 0.61 |
| Sedation | 0 (0%) | 66 (100%) | 0 (0%) | 74 (100%) | – |
| Dry mouth | 3 (4.4%) | 63 (95.6%) | 0 (0%) | 74 (100%) | χ2 (df = 1, N = 140) = 3.44, P = 0.10a |
| Urinary complications | 3 (4.4%) | 63 (95.6%) | 0 (0%) | 74 (100%) | χ2 (df = 1, N = 140) = 3.44, P = 0.10a |
Note:
a
Fisher’s Exact test.